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The yeast Hog1 protein is both functionally and structurally
similar to the mammalian p38, belonging to the same family of
mitogen-activated protein (MAP) kinases and responding to
extracellular changes in osmolarity. Since p38 mediates lipopo-
lysaccharide (LPS) effects inmammalian cells,wenow tested the
responsiveness ofHog1upon exposure of the yeast Saccharomy-
ces cerevisiae to bacterial LPS. In the presence ofEscherichia coli
LPS (100 ng/ml) and an endotoxically active, hexaacylated, syn-
thetic lipid A (compound 506; 100 ng/ml), Hog1 becomes phos-
phorylated with a maximum of phosphorylation between 3 and
6 h, whereas a tetraacylated, inactive form of lipid A (compound
406) didnot cause anymodification in thephosphorylation state
of Hog1. A triple labeling immunocytochemical study showed
that phosphorylated Hog1 translocates into the nucleus after a
90-min incubation and becomes sparsely located in the cyto-
plasm.The translocationof thephospho-Hog1 is precededby an
increased expression of the HOG1 gene and concomitant with
the expression of theHog1 target gene,GPD1.We also observed
that cells unable to synthesize Hog1 do not resist LPS as effi-
ciently as wild-type cells. We conclude that the yeast S. cerevi-
siae is able to respond to the presence ofGram-negative bacteria
endotoxin and that Hog1 is involved in this response.
In response to stress, cells have developed a variety of mech-
anisms to give a specific and adaptative response. The stress
responses rely on the recognition of the specific stress through
a cellular sensor followed by a signal transduction pathway that
often involves one or more chains of enzymatic activities, lead-
ing to several coordinated intracellular actions, which ulti-
mately results in a modification of gene expression and in the
production of proteins aimed to alleviate the consequences of
stress. The cellular response to stress generally involves mito-
gen-activated protein kinase (MAPK)2 cascades, which are
common andhighly conserved signalingmodules found in both
higher and lower eukaryotic cells (1). A prototype of the stress-
activated protein kinases (SAPK) family is the yeast Hog1MAP
kinase, which specifically responds to increased extracellular
osmolarity and is essential for cell survival under these condi-
tions (Ref. 2, and for review, see Refs. 3 and 4). Saccharomyces
cerevisiae detects and responds to high extracellular osmolarity
through the high osmolarity glycerol (HOG) MAPK pathway
(5, 6). Upon phosphorylation by the dual specific kinase Pbs2,
Hog1 is translocated into the nucleus (7, 8), where it directly
targets several transcription factors leading to changes of gene
expression (9–13). A portion of activated Hog1 is apparently
also present in the cytoplasm to mediate post-transcriptional
and translational effects (14–16), to achieve osmoadaptation.
Lately, it was described that Hog1 modulates the activity of
membrane transporters, i.e. acting directly in cytoplasmic tar-
gets (17). Until recently, it was generally accepted that Hog1
was just involved in the response to increased extracellular
osmolarity, but recent reports showed that it is also activated by
heat stress (18), oxidative stress (16, 19, 20), and citric acid
stress (21).
The Hog1 homologue in mammalian cells is p38, which is
structurally related, sharing a Thr-Gly-Tyr (TGY) dual phos-
phorylation motif (22). Furthermore, p38 has the ability to res-
cue a S. cerevisiae hog1 mutant in a hyperosmotic environ-
ment (22, 23) or under oxidative stress (19). There is also a
functional homology between yeastHog1 and p38 since p38 is a
central mediator of the hyperosmotic (Ref. 24, and for review,
see Ref. 25) and of the oxidative (26, 27) stress response in
mammalian cells. It has also been reported that the human
MTK1 can complement the MAPKKK mutants, ssk2 ssk22
(28).
However, it is still unknown whether the functional homol-
ogy between Hog1 and p38, in S. cerevisiae, can be extended to
other stress situations besides osmolarity and oxidative stress.
In particular, it is well established that one of the main roles of
p38 is the regulation of the inflammatory response (27, 29). The
prototypical activator of cells of the immune and inflammatory
systems is lipopolysaccharide (LPS), the component of the
outer leaflet of the cell wall of Gram-negative bacteria. LPS
activates macrophages, a pivotal cell type in LPS response, trig-
gering the production and release of proinflammatory cyto-
kines and nitric oxide (29) through the activation of the p38
kinase pathway (30, 31). The inflammatory activity of LPS is due
to the lipid moiety of the molecule, termed lipid A, and usually
referred as the bacterial endotoxin. Situations where lipid A, an
amphiphilic compound, is exposed result in the immunostimu-
lation of the host (31). Thus, the present study was designed to
test whether the p38 MAP kinase yeast homologue, Hog1, is
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also activated upon exposure of S. cerevisiae to bacterial
endotoxin.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions—The S. cerevisiae strains
used in this study were wild-type W303-1A (Mata ade 2-1 can
1-100 his 2-11,15 leu 2-3,112 trp1-1 ura3-1), provided by Pro-
fessor Johan Thevelein (Katholieke University of Leuven, Bel-
gium), and its derivative YSH 444 (hog1:: TRP1) mutant,
obtained fromProfessor StefanHohmann (32). Yeast cells were
grown at 30 °C in yeast nitrogen base (YNB) medium supple-
mented with the appropriate selective amino acids and bases
and 2% glucose. Growth was assessed by measuring the optical
density at a wavelength of 640 nm (A640 nm). The cells were
grown to midlog phase, divided, and incubated with 100 ng/ml
(33) Escherichia coli LPS (Sigma), lipid A compound 506 or 406
(Peptides International, Louisville, KY) or with NaCl 0.8 M (as a
control) (34).
Western Blot Analysis—Protein extracts were obtained using
the urea/SDS method as described previously (35). Samples
were boiled at 95 °C for 10 min and then separated by 10%
SDS-polyacrylamide gel electrophoresis. The proteins were
transferred onto polyvinylidene difluoride membranes (0.45
m, from Amersham Biosciences), which were blocked for 1 h
at room temperature in Tris-buffered saline medium (200 mM
Tris and 150 mM NaCl, pH 7.6) containing 0.1% Tween 20
(TBS-T) with 5% bovine serum albumin. Dual phosphorylation
of Hog1 was detected using a rabbit antibody against the dually
phosphorylated (Thr-174 and Tyr-176) form of p38 (Cell Sig-
naling), 1:250 in TBS-T with 3% bovine serum albumin) in
which the membranes were incubated overnight at 4 °C. After
three washing periods with TBS-T, the membranes were incu-
bated with alkaline phosphatase-conjugated goat anti-rabbit
secondary antibody (Amersham Biosciences; 1:10,000) during
1 h at room temperature. Afterwashing three timeswithTBS-T
and incubationwith enhanced chemifluorescence (ECF, Amer-
sham Biosciences) for 5 min, the membranes were analyzed
using the VersaDoc 3000 (Bio-Rad). Themembranes were then
stripped and reprobed for total Hog1 protein. Briefly, themem-
branes were incubated for 1 h at room temperature with 0.1 M
glycine, pH 2.3, to strip the previous antibodies and probed
using a goat anti-C-terminal Hog1p antibody (Santa Cruz Bio-
technology, SantaCruz, CA; 1:500) as described above, using an
alkaline phosphatase-conjugated anti-goat secondary antibody
(Calbiochem, UK; 1:5,000).
Immunocytochemistry—10ml of cells were harvested by cen-
trifugation, resuspended in 4% paraformaldehyde at room tem-
perature for 15min, and washed twice with PBS (140mMNaCl,
3 mM KCl, 20 mM NaH2PO4, 15 mM KH2PO4, pH 7.4). Cells
were spheroplasted by resuspension in phosphate buffer (1.2 M
sorbitol, 100mMKH2PO4, pH 7.5), with 0.17% -mercaptoeth-
anol and 1mg/ml zymolyase 100T (Seikagaku, Japan) and incu-
bated at 30 °C with gentle shaking for 45 min. Spheroplasts
were washed once with PBS and resuspended in phosphate
buffer. Then, the spheroplasts were added to the coverslips,
previously coatedwith poli-L-lysine, allowed to adhere for 1 h at
37 °C, and blockedwith PBSwith 3%bovine serumalbumin and
0.1%Tween 20 (blocking solution) for 30min. The spheroplasts
were then incubated for 2 h with the primary antibodies, rabbit
anti-phospho-p38 MAP kinase (Cell Signaling; 1:100) and goat
anti-Hog1 (Santa Cruz Biotechnology; 1:400), prepared in the
blocking solution. The coverslips were washed three times with
PBS and incubated, in the dark, for 2 h, with the secondary
antibodies (Alexa Fluor 488-labeled donkey anti-rabbit and
Alexa Fluor 594-labeled donkey anti-goat antibodies, Molecu-
lar Probes). As a control, spheroplasts were incubated only with
secondary antibodies, without previous incubation with pri-
mary antibodies. The coverslips were then washed twice with
PBS and incubated with 15 g/l Hoechst 33342 (Molecular
Probes) for 5 min, washed three times with PBS, and mounted
on Prolong antifade (Molecular Probes). The coverslips were
analyzed on a Zeiss Axiovert 200 inverted fluorescence micro-
scope, with a100 objective equippedwith a cooledCCD cam-
era (Roper Scientific, Tucson, AZ) and analyzed with
MetaFluor 5.0 software. The final figures were prepared using
Paint Shop Pro 7 without further manipulation.
Gene Expression—Total mRNA was extracted from yeast
cells (5 107 cells/ml) in control conditions (no stress) or after
exposure to 100 ng/ml LPS, using an RNeasy mini kit (Qiagen,
Izasa, Portugal) according to the manufacturer’s instructions
for yeast cells. mRNA samples (3 g) were reverse transcribed
using Transcriptor first-strand cDNA synthesis kit for reverse
transcription-PCR (RocheDiagnostics, Lisbon, Portugal). After
denaturation at 65 °C for 10 min in aWhatman Biometra ther-
mocycler, in the presence of 60 M random hexamer primer,
mRNA samples were incubated with 20 units of Protector
RNase inhibitor, 1 mM dNTPs, and 10 units of transcriptor
reverse transcriptase, at 25 °C for 10 min and 55 °C for 30 min.
The real-time PCR reactions were performed in a LightCy-
cler 2.0 (Roche Diagnostics), using a LightCycler Fast Start
DNA MasterPlus SYBR Green I kit (Roche Diagnostics). The
PCR reaction was based on the SYBRGreen method, according
to themanufacturer’s instructions, which relies on primer spec-
ificity and requires no detection probes. The primers used in
the real-time LC protocols were for HOG1, forward primer
5-GATGCCTTGGCTCATCCTTA-3 and reverse primer
5-ACTGTATGGCCTGGTTACCG-3; for GPD1, forward
primer 5-TTTTGCCCCGTATCTGTAGC-3 and reverse
primer 5-CGTTGTTACCCCAGCCTAGA-3; and for the ref-
erence gene 18S, forward primer 5-CGGCTACCACATC-
CAAGGAA-3 and reverse primer 5-GCTGGAATTAC-
CGCGGCT-3. These primers were designed using OLIGO6
software (Cambio, Cambridge, UK). The selected sets of prim-
ers were checked against GenBankTM using BLAST to confirm
their gene specificity. Every test run included RNase-free water
as a negative control. The amplification and detection were
performed using the following parameters: a preincubation at
95 °C for 10 min for FastStart TaqDNA polymerase activation
followed by 45 cycles of amplification: denaturation at 95 °C for
10 s, annealing at 60 °C for 10 s, and extension at 72 °C for 17 s.
After the 45 cycles, melting curve analysis was performed to
confirm product specificity. The melting curve analysis was
achieved by heating themixture up to 95 °C and then cooling to
65 °C for 15 s and then slowly (0.1 °C/s) heating back to 95 °C.
Raw data were analyzed by relative quantification using the
2CT method (36).
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Viability Assay—The sensitivity to LPS was evaluated in
pregrown cells at 30 °C until anA640 nm of 0.8–1. The cells were
then divided and incubated without or with 100 ng/ml LPS or,
as a control, with 0.8 M NaCl. To quantify the number of viable
cells during the incubation period, 100-l aliquots were taken
and plated into Petri dishes. The number of colonies was
counted after 3 days at 30 °C. Under these conditions, each
colony represents a viable cell. For the spotting experiments,
10-fold serial dilutions of an exponentially growing culture
were spotted onto YNB agar plates supplemented without or
with 100 ng/ml LPS or as a control, with 0.8 MNaCl. Plates were
incubated 48 h at 30 °C before being photographed.
RESULTS
Hog1 Protein Is Phosphorylated upon Exposure to Bacterial
Lipopolysaccharide—To determine whether the exposure of
yeast cells to bacterial LPS results in the activation of Hog1
protein, we quantified the activation of Hog1 by measuring the
formation of its activated form, the dually phosphorylated form
(Thr-174/Tyr-176) of Hog1, using a selective antibody (34).
Phosphorylation of Hog1 was investigated by Western blot
analysis of cells incubated with 100 ng/ml LPS, a concentration
able to trigger p38 activation/phosphorylation in human neu-
trophils (33). After 30 min of incubation with LPS, it was pos-
sible to detect the phosphorylated form of Hog1 (Fig. 1A). The
levels of phosphorylated Hog1 then increased continuously up
to 180–360 min (Fig. 1A), when the maximal phosphorylation
was observed. The levels of phosphorylated Hog1 continuously
decreased up to 12 h of incubation with LPS (Fig. 1A). As a
positive control, we evaluated the degree of phosphorylation of
Hog1 under osmotic stress (0.8 M NaCl) (34). As observed in
previous studies (34), after 5 min of exposure to 0.8 M NaCl,
Hog1 became phosphorylated, reaching a transient maximal
phosphorylation at 10–30 min and remaining detectable until
FIGURE 1.Hog1 protein is phosphorylated upon LPS exposure. A, representativeWestern blot showing the dual phosphorylation (Phospho) of Hog1 upon
hyperosmotic stress (positive control blots on the left) and LPS exposure (blots on the right). Soluble protein extracts were prepared from cells incubatedwith
0.8 M NaCl and cells incubated with 100 ng/ml LPS at the time points indicated in the figure. The dually phosphorylated form of Hog1 was detected using a
previously validated anti-phospho-p38 antibody. The same Western blot membranes were reprobed against total Hog1 (lower blots), using a polyclonal
anti-C-terminal Hog1 antibody, to calculate the ratio of density phospho-Hog1/density Hog1. B, illustrates the different time course phosphorylation of Hog1
in cells exposed toosmotic stresswhen comparedwith those exposed to LPS. The incubationwith compound506 (a proinflammatory, hexaacylated, synthetic
E. coli like-lipid A) or with a commercial E. coli LPS (100 ng/ml) followed the same kinetics (results not shown), with amaximum of phosphorylation at 360min
of incubation (C ), whereas compound406 (the inactive, tetraacylated, formof lipidA) didnot cause anymodification. The values are shownas themeans S.E.
of three different Western blots from three different experiments.
Hog1 Protein Activation upon Endotoxin Exposure
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90 min (Fig. 1A). To ascertain that the increase in phosphoryl-
ated Hog1 levels does not represent a possible increase in Hog1
expression but rather of its phosphorylation, we followed the
total levels of Hog1. As illustrated in the reprobed membranes
using an anti-C-terminalHog1p antibody,we found an increase
in the density ofHog1 upon exposure to LPS (Fig. 1A). Thus, we
calculated the ratio between the relative density of phosphoryl-
ated Hog1 and total Hog1 for the cells exposed to LPS or NaCl
0.8 M (Fig. 1B) to adequately compare the level of phosphoryl-
ation induced by hyperosmolarity and by LPS, irrespective of
changes in the total levels of Hog1. As illustrated in Fig. 1B,
hyperosmolarity induced a faster Hog1 phosphorylation
(reaching a maximum of phosphorylation at 10–30 min) than
that observed upon incubation with LPS (reaching a maximum
of phosphorylation at 180–360min), which displayed a delay of
30 min. This ratio analysis also indicated that the degree of
phosphorylationwas higher in cells exposed to LPS than in cells
incubatedwithNaCl 0.8 M (Fig. 1B). Regardless of the phospho-
rylation kinetics, taken together, these data clearly show that
LPS exposure induces Hog1 phosphorylation.
Since there are reports showing that commercial LPS con-
tains several bioactive contaminants (37, 38) that could con-
found the interpretation of our observed LPS-induced effects,
we went on to study whether lipid A (the LPS component that
ultimately binds the TLR4 receptor and induces activation of
p38) is able to stimulate, in yeast, the phosphorylation of
Hog1p. We used two different kinds of lipid A, a proinflamma-
tory, hexaaacylated, syntheticE. coli-like lipidA, the compound
506 (39, 40) and a tetraacylated lipid A that antagonizes the
inflammatory response, the compound 406, which is endotoxi-
cally inactive (41–43). We observed that only compound 506,
but not its endotoxically inactive analogue, compound 406,
results in an active phosphorylation of the Hog1 protein (Fig.
1C). The methodology used by us in the preparation of suspen-
sions of both forms of lipid A results in the formation of pure
aggregates of each form of lipid A, according to the results
described by Mueller et al. (39). Also, according to these
authors, the stimulation of mononuclear cells with pure aggre-
gates results in a lower production of tumor necrosis factor-,
i.e. activation, whereas a mixture of several compounds results
in a higher stimulation, a result mimicked by suspensions of
natural LPS. In our experiments, we also found that incubation
with similar concentrations of compound 506 and E. coli LPS,
during 6 h, results in a lower level of Hog1 phosphorylation in
the presence of the synthetic lipid A (Fig. 1C).
The difference between the two forms of lipid A now
described by us also excludes the hypothesis that the effect
observed upon exposure to LPS or lipid A could be due to a
disturbance of the cell membrane by hydrophobic substances
since the biologically inactive synthetic lipid A compound 406
does not induce Hog1 phosphorylation. Besides, compound
406 incorporates more efficiently with phospholipid cell mem-
branes than other amphiphilic substances, a process mediated
by the LPS-binding protein (40). Thus, these findings suggest
that the effects triggered by LPS are not due to a nonspecific but
are likely to be receptor-mediated, although this still remains to
be fully established.
Expression of HOG1 Gene Is Increased upon Exposure to LPS—
The observation that the total levels of Hog1 increased during
exposure to LPS (Fig. 1A, right panel) led us to study whether
LPS modified the relative levels of expression of the HOG1
gene. After a 90-min exposure to 100 ng/ml LPS, the levels of
HOG1 mRNA were increased 6-fold when compared with the
control (without incubation with LPS), as evaluated by SYBR
Green real-time PCR (Fig. 2). This increased level of expression
of HOG1 was maintained until a 3-h incubation with LPS (Fig.
2). However, at 6 h of incubation, the relative expression of this
gene decreased to control levels (Fig. 2). These results show that
upon LPS exposure, in addition to an increase in Hog1 phos-
phorylation, there is an up-regulation of the expression of
HOG1. Furthermore, the comparison of the kinetics of the LPS-
induced changes inHOG1mRNA and of phosphorylated Hog1
indicates that the up-regulation of HOG1 mRNA levels pre-
cedes the maximal levels of phosphorylated Hog1.
Hog1p Is Translocated to the Nucleus upon LPS-induced
Phosphorylation—Upon activation by hyperosmotic stress,
Hog1 translocates into the nucleus, from where it coordinates
the expression of numerous genes (7, 8), controlling the activity
of specific transcriptional activators and repressors (9, 10,
43–45). Therefore, we decided to examine whether the Hog1
protein is translocated to the nucleus upon exposure to LPS. To
monitor the subcellular localization of the inactive/dephospho-
rylated and the active/phosphorylated forms of Hog1 protein,
we performed a triple labeling immunocytochemical assay.We
labeled phosphorylated Hog1 (green) and total Hog1 (red)
using the same antibodies used in theWestern blot analysis. To
evaluate the nuclear localization of the phosphorylated form of
the Hog1 protein, we labeled yeast genomic DNA using the
fluorescence probe Hoechst 33342 (blue). Triple co-localiza-
tion (white) shows the presence of phosphorylated Hog1 in the
nucleus. We performed this immunocytochemical assay in
unstressed yeast cells, in yeast cells exposed to 100 ng/ml LPS
FIGURE 2.HOG1mRNA levels are up-regulated upon LPS exposure. Yeast
cells were exposed to 100 ng/ml LPS during 12 h. Samples were taken at 30,
90, 180, 360, and 720 min of incubation, and total mRNA was extracted and
reverse-transcribed to cDNA. The variation ofHOG1mRNA levelswas assayed
by SYBR Green real-time PCR in reactions normalized to contain initial equal
amounts of cDNA using the reference gene 18S. HOG1 mRNA levels were
maximally increased 6-fold at 90min, returning to control levels at 360min of
LPS exposure. The results are mean  S.E. in percentage of control (set as
100%) of three experiments from three independent preparations. *,p 0.01
versus control (100%).
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for different time periods, or in yeast cells exposed to 0.8 M
NaCl, as a positive control (Fig. 3).
As described previously for hyperosmotic stress conditions
(7) and now demonstrated by us using an immunocytochemis-
try assay with specific antibodies for
both total and phospho-Hog1, after
phosphorylation, Hog1 transiently
accumulates in the nucleus, with a
time course matching its phospho-
rylation status (compare the effects
of hyperosmotic stress in Figs. 1 and
3). Likewise, exposure to LPS (100
ng/ml) for 30 min led to an increase
in the levels of the phosphorylated
form of Hog1, which was solely
located in the cytoplasm. After 90
minofincubationwithLPS,thephos-
phorylated form of Hog1 was pre-
dominantly localized in the cyto-
plasm, although there was already
some phospho-Hog1 located in the
nucleus (Fig. 3). Only between 3 and
6 h of incubation with LPS was it
possible to find a clear accumula-
tion of phosphorylated Hog1 pro-
tein inthenucleus,albeit somephos-
phorylated Hog1 remained in the
cytoplasm. After 12 h of incubation
with LPS, the levels of phosphoryla-
ted Hog1 decreased, in agreement
with the data obtained in the West-
ern blot analysis (Fig. 1). The
remaining phosphorylated Hog1
was restricted to the cytoplasm,
which indicates that its nuclear
localization is a transient event.
This suggests that upon exposure to
LPS, Hog1 is translocated into the
nucleus in a transient manner that
correlateswithitstimecourseofphos-
phorylation, as observed in yeasts
under hyperosmotic stress.
Exposure to LPS Increases the
Expression of GPD1—One of the
main strategies used by yeasts in
osmoadaptation is the production
and accumulation of the compatible
osmolyte, glycerol (reviewed in
Ref. 4). To achieve it, there is an
increased expression of genes
encoding enzymes in the glycerol
production pathway. One of these
genes is GPD1, which encodes glyc-
erol-3-phosphate dehydrogenase.
The HOG pathway plays a central,
albeit not exclusive, role in osmotic
induction of GPD1 expression (10,
46). Following our observation that
Hog1 is phosphorylated in the presence of LPS, we decided to
evaluate whether GPD1 expression is also increased upon LPS
exposure. For that purpose, total mRNA was extracted from
yeast cells and reverse-transcribed to cDNA. The variation of
FIGURE3.LPSexposure triggersa transientphosphorylationofHog1proteinand its translocation to the
nucleus. A triple labeling immunocytochemical assay was performed in control cells (No stress), in cells sub-
jected to high osmolarity (i.e. exposed to 0.8 MNaCl), and in cells exposed to 100 ng/ml LPS for the timeperiods
indicated. The immunocytochemical identification of phosphorylated Hog1 (p-Hog1, second column of panels
from the left; stained green) was achievedusing a selective antibody against the dually phosphorylated formof
p38 MAP kinase. The immunocytochemical identification of Hog1 was achieved using a polyclonal antibody
against the C-terminal of Hog1 protein (middle column of panels; stained red), and for the identification of the
cell nucleus, yeast genomic DNA was labeled using the fluorescence probe Hoechst 33342 (second column of
panels from the right; stained blue). Merged images (right panels) illustrate that there is a nuclear localization in
addition to a cytosolic localization of phosphorylatedHog1 at 90min, 3 h, and 6hof incubationwith LPS (triple
co-localization yieldingwhite). Note that LPS exposure only triggered the nuclear localization of the phospho-
rylated formof Hog1 after 30minwith amaximal effect at 3–6 h,whereas high osmolarity induced localization
ofphospho-Hog1peakedat 10min (maintaineduntil a 30-min incubation, results not shown) anddisappeared
at 3 h. The images shown are representative of five experiments producing qualitatively identical results.
Hog1 Protein Activation upon Endotoxin Exposure
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GPD1mRNA levels was assayed by SYBRGreen real-time PCR
in reactions normalized to contain initial equal amounts of
cDNAusing the reference gene 18S. After a 90-min exposure to
LPS, the expression of GPD1 was increased 6-fold, reaching a
maximal increase of 9-fold at 3 h of incubation when compared
with the control (no LPS) (Fig. 4). After 6 h of incubation with
LPS, the GPD1 mRNA levels were lower and similar to the
control levels. The time course of LPS-induced increase of
GPD1mRNA levelsmatches the LPS-induced increase inHog1
phosphorylation and translocation to the nucleus (90 min–3 h)
(compare the time course of LPS effects in Figs. 3 and 4), mean-
ing that immediately after being translocated to the nucleus,
phospho-Hog1 controls the initiation of transcription ofGPD1
mRNA. This strongly suggests that upon LPS exposure, Hog1 is
not only phosphorylated and translocated to the nucleus but is
also in a catalytically active state, up-regulating GPD1 mRNA
levels.
hog1 Mutant Is LPS-sensitive—To evaluate whether LPS
exposure affects the growth of yeast cells andwhether theHog1
protein is involved in this effect, serial dilutions of mid-expo-
nential-phase cultures of wild-type S. cerevisiae and hog1
mutant were spotted onto YNB agar plates in the presence of
100 ng/ml LPS. Growth of wild-type S. cerevisiae was not
affected either in the presence of 100 ng/ml LPS or in the pres-
ence of 0.8 M NaCl. As a control, it was confirmed that the
growth of hog1 mutant was inhibited when this strain was
spotted onto 0.8MNaCl-YNB agar plates (Fig. 5A), according to
the key role of Hog1 in osmoadaptation (2). Likewise, the
growth of hog1mutant was also inhibited upon exposure to
100 ng/ml LPS (Fig. 5A). In a viability assay, pregrown yeast
cells, wild-type and hog1 mutant, were incubated in YNB
medium without or with 100 ng/ml LPS. Although the via-
bility of the wild-type strain was not affected during the 12-h
incubation period (Fig. 5B), the capacity of growth of the
hog1 mutant decreased during
this period (Fig. 5B). These results
clearly suggest that the Hog1 pro-
tein plays a key role in the
response to stress caused by expo-
sure to bacterial lipopolysaccharide.
DISCUSSION
Previous studies focusing in the
response to extracellular changes in
osmolarity showed a physiological
analogy between mammalian p38
stress kinase and the yeast Hog1
protein, as expected from their
extensive sequence homology (22).
The present study extends the phys-
iological homology between yeast
Hog1 and mammalian p38 protein
to the context of the response to
bacterial endotoxin, a prototypical
trigger of inflammatory responses
in mammalian systems (29). Thus,
we report that S. cerevisiae respond
to LPS exposure by increasing the
expression and the degree of phos-
phorylation of the Hog1 protein, an
effect mimicked by an endotoxically
active synthetic lipid A but not by a
chemically similar but biologically
inactivesyntheticlipidA.Oncephos-
FIGURE 4.GPD1mRNA levels are up-regulated upon LPS exposure. Yeast
cells were exposed to 100 ng/ml LPS during 12 h. Samples were taken at 30,
90, 180, 360, and 720 min of incubation, and total mRNA was extracted and
reverse-transcribed to cDNA. The variation ofGPD1mRNA levels was assayed
by SYBR Green real-time PCR in reactions normalized to contain initial equal
amounts of cDNA using the reference gene 18S. GPD1 mRNA level up-regu-
lation was evident at 90min and reached its maximum at 180min of incuba-
tion with LPS. The results are mean  S.E. in percentage of control (set as
100%) of three experiments from three independent preparations. *,p 0.01
versus control (100%).
FIGURE 5. LPS exposure inhibits the growth of hog1 mutant. By using a spotting assay (A), the growth
pattern of S. cerevisiaeW303 and hog1mutant was evaluated in control conditions (YNBmedium) and in the
presence of 100 ng/ml LPS or in the presence of 0.8 M NaCl. W303 growth was not modified either in the
presence of LPS or in hyperosmolar medium (left photographs). In contrast, hog1 displayed LPS-sensitivity,
although at a lesser extent when compared with that observed in hyperosmolarity stress. The photographs
displayed are representative of five experiments yielding qualitatively identical results. The viability of the two
strains to LPS (B) was assessed in cells pregrown at 30 °C until an A640 nm of 0.8–1.0 and resuspended in the
same medium without or with 100 ng/ml LPS. At the time points indicated, 100-l aliquots were taken and
spread into Petri dishes. After 3 days at 30 °C, the number of colonies was counted. The results aremean S.E.
of five independent experiments.
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phorylated, Hog1 is then translocated into the nucleus. Fur-
thermore, we showed that Hog1 plays a key role for the yeast
adaptative response to LPS challenge since the growth of a
hog1mutant was inhibited by exposure to LPS in contrast to a
wild strain. These results show that, as occurred for hyperos-
motic stress, there is a functional analogy between yeast Hog1
and the mammalian p38 in response to LPS exposure.
Hog1, a prototype member of the stress-activated protein
kinase family, is constitutively expressed in yeast where it
plays a key role in the adaptative response to different stress-
ful conditions such as osmotic (2), oxidative (16, 19, 20), heat
(18), or citric acid stress (21). The exposure of S. cerevisiae to
high osmolarity (reviewed in Ref. 4) leads to a rapid (less than
30 min) and sustained (up to several hours depending on the
severity of the hyperosmotic conditions) phosphorylation of
the Hog1 protein. Upon phosphorylation, Hog1 is translo-
cated into the nucleus (7, 8), where it directly targets several
transcription factors leading to a change of gene expression
(9, 10, 13). In particular, there is an increased expression of
the enzymes required for the synthesis of a major osmolyte,
glycerol, especially GPD1, the gene that codes for glycerol-
3-phosphate dehydrogenase (5). Interestingly, a portion of
the activated Hog1 protein is apparently also present in the
cytoplasm to mediate post-transcriptional and translational
effects involved in osmoadaptation (14, 15). We now con-
firmed the key steps of Hog1 activation and nuclear translo-
cation in yeast cells exposed to 0.8 M NaCl. Most impor-
tantly, we report for the first time that the exposure of yeast
cells to LPS also engages the phosphorylation of Hog1, its
translocation to the nucleus, and the activation of GPD1
gene expression. However, the kinetics of the LPS-induced
Hog1 phosphorylation and translocation into the nucleus
was slower than that induced by osmotic stress. In fact,
whereas the osmotic stress-induced Hog1 phosphorylation
peaked after 10–30 min, the LPS-induced Hog1 phosphoryl-
ation peaked at 180–360 min. Likewise, the osmotic stress
induced translocation of phosphorylated Hog1 into the
nucleus peaked at 10 min, whereas that caused by LPS
peaked at 180–360 min. It has been described that several
concentrations and/or different osmotically active sub-
stances have different kinetics of phosphorylation, subcellu-
lar translocation, and activation of gene expression (8, 10, 33,
47). However, this delay in the recruitment of the Hog1 by
LPS may also be related to the observed ability of LPS to
enhance the density of total Hog1 as a likely result of the
increased levels of HOG1 mRNA. Nevertheless, apart from
this kinetic difference, the stress response to high osmolarity
and to LPS exposure in yeast appears to follow a similar
Hog1-dependent pathway. In fact, in contrast to other types
of stressful conditions (exposure to heat, to weak organic
acids, or to ethanol) that failed to induce the import of phos-
phorylated Hog1 into the nucleus (7, 8), we now found that
LPS effectively triggers the translocation of phosphorylated
Hog1 protein into the nucleus. This was directly confirmed
by immunocytochemistry using a previously validated anti-
body against phosphorylated Hog1 in yeast (34) as well as by
the ability of LPS to increase the expression of GPD1, which
is regulated by the presence of phosphorylated Hog1 in the
nucleus (32, 48). Recently, it was described that Hog1, acti-
vated by oxidative stress, translocates to the nucleus at a
lower extent than the observed under hyperosmolarity, with
a phosphorylation peak at 45 min (16).
We also observed that the responses to LPS and high osmo-
larity were transient, suggesting that the Hog1 pathway might
be controlled by feedbackmechanisms, like dephosphorylation
by Ser/Thr phosphatases (49) and by Tyr phosphatases (50), as
suggested by others (for a review, see Ref. 4). We now observed
that after 6 h of incubation with LPS, all the nuclear Hog1 shifts
to the cytoplasm. Surprisingly, part of this cytoplasmic protein
remains phosphorylated, even 12 h after the beginning of the
exposure to LPS. This leads us to the conclusion that the con-
trol mechanisms of theHOGpathway in response to LPS expo-
sure are different from those observed under other stress situ-
ations and confirms the hypothesis that the nuclear export of
phospho-Hog1 is not strictly dependent on its dephosphoryla-
tion (51) and that, upon exposure to LPS, phosphorylatedHog1
is involved in cytoplasmic processes, kept active while LPS is
present. Likewise, in Debaryomyces hansenii, it was observed
that, under extreme osmotic conditions, Hog1 is maintained
phosphorylated in the cytoplasm, and the authors related this
fact as a need to resist a continuous aggression (52).
Some of the differences found between the recruitment of
the HOG pathway by high osmolarity and by LPS may be
related to the initial sensing devices engaged by the two types of
stress conditions. In fact, the molecular determinant of the
yeast high osmolarity sensor have been unraveled as two inde-
pendent branch sensors, one being the “two-component”
osmo-sensing complex Sln1-Ypd1-Ssk1 (53, 54) and the other
being the membrane-bound protein Sho1 (55). In contrast, the
pathways by which yeast signals the presence of LPS are
unknown since this report provides the first demonstration that
yeast can respond to LPS. In particular, it has not been defined
whether yeasts are endowed with a receptor analogous to Toll-
like receptors, which sense LPS in mammalian cells (31). How-
ever, the currently described ability of the hexaacylated lipid A
but not of the tetraacylated lipid A to engage the Hog1 phos-
phorylation is highly suggestive of the involvement of a recep-
tor since the former but not the later form of lipid A is an
endotoxin acting through Toll-like receptors in mammalian
cells (40). At least, the obtained results demonstrate that yeast
possesses a specific mechanism to recognize for LPS (i.e. lipid
A), similar to the one found in mammalian cells but not in
Drosophila cells (56).
From an evolutionary point of view, this ability of yeast to
sense bacterial LPS may be an important pathway for the opti-
mization of yeast survival. In fact, yeast cells have to cope with
various adverse conditions in their environment, including tox-
ins from plant, fungi, and bacteria, which makes it logical that
yeasts should have evolved mechanisms to sense and adapt to
the presence of bacterial toxins. Particularly in situations of
mixed infectionswhere yeasts are both exposed to live and lysed
bacteria (due to macrophage attack), such an LPS-induced/
sensing mechanism would be an advantage for the survival of
yeast. The presently observed inhibition of growth upon expo-
sure to LPS in a hog1 mutant clearly shows that the recruit-
ment of this HOG1-dependent pathway is crucial for the adap-
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tative response of yeast to LPS. Finally, the parallel between the
responses of yeast Hog1 protein to LPS with the key role of
mammalian p38 in inflammatory response opens the possibility
of considering the use of yeasts as a basic model to study the
signal transducing mechanisms underlying inflammatory
responses at the cellular level and to assist in the search and
screening of new potential anti-inflammatory drugs.
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